Plain-English translation of NCT06562569 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Parkinson's Disease research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a non-invasive vagal nerve stimulation (ncVNS) device—a handheld tool you apply to the left side of your neck—to see if it can help improve walking and reduce freezing of gait in Veterans with Parkinson's disease. The device is already approved to treat migraines, and researchers believe it may help reduce inflammation and improve brain signaling related to movement. You would use this treatment at home for a few minutes each day over 4 weeks.
Walking problems and freezing of gait are among the most disabling symptoms of Parkinson's disease and a major cause of falls and loss of independence in Veterans. Current medications don't adequately address these walking problems, so researchers are testing this non-invasive, at-home treatment as a new option that might complement existing care.
You likely qualify if…
You likely don't qualify if…
If you're selected, you'll be randomly assigned to one of three groups: one group will use the neck stimulation device at a low intensity for 2 minutes daily, another will use it at a higher tolerated intensity for 12 minutes daily, and a third group will continue with their usual care as a comparison. All stimulation is done at home by you, and the entire study lasts 4 weeks. Researchers will measure your walking ability, balance, and freezing episodes before, during, and after the study period.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
United States